Table. 2.

Table. 2.

Treatment and prognostic variables of Osteosarcoma cohort

Variable Total (n=13) Patients with event (n=6) Patients without event (n=7) P-value
Metastatic disease 4 (30.8%) 3 (50.0%) 1 (14.3%) 0.2657
Lung mets 4 (30.8%) 3 (50%) 1 (14.3%)
Chemotherapy 13 (100%) 6 (100%) 7 (100.0%) 0.1923
Limb salvage surgery 8 (61.5%) 3 (50.0%) 5 (71.4%) 0.7552
Negative microscopic margins 11 (84.6%) 6 (100.0%) 5 (71.4%) 0.4615
Tumor necrosis >90% 3 (23.1%) 0 3 (42.9%) 0.1923
Functional disability at follow-up 4 (30.8%) 0 4 (57.1%) 0.0699
Death 4 (30.8%) 4 (66.6%) 0 0.0210
Disease progression as cause of death 4 (30.8%) 4 (66.6%) 0 0.0210
Clin Pediatr Hematol Oncol 2024;31:29-35
© 2024 Clin Pediatr Hematol Oncol